News from Thoratec

March 04, 2010



Thoratec Presentation at Raymond James Conference to Be Webcast

PLEASANTON, Calif., March 4, 2010 /PRNewswire via COMTEX/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that it will be participating in the Raymond James Institutional Investors Conference on Wednesday, March 10. David V. Smith, executive vice president and chief financial officer, will provide an update on the company, beginning at 9:50 a.m., Eastern Standard Time (6:50 a.m., Pacific Standard Time). The presentation will be available through the conference web site at http://www.wsw.com/webcast/rj54/thor/ or on the company's web site at http://www.thoratec.com. ...

January 28, 2010



Thoratec Reports a 19 Percent Increase in Annual Revenues as Cardiovascular Division Revenues Increase 30 Percent in 2009

COMPANY INITIATES ROLL OUT OF HEARTMATE II(R) FOR DESTINATION THERAPY FOLLOWING APPROVAL EARLIER THIS MONTHPLEASANTON, Calif., Jan 28, 2010 /PRNewswire via COMTEX/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that a 30 percent growth in revenues from its Cardiovascular Division in fiscal 2009 led to a 19 percent increase in total 2009 revenues versus those in fiscal 2008. For the year ended January 2, 2010, revenues were $373.9 million versus $313.6 million in the prior year. Revenues for the fourth quarter of fiscal 2009 were $104.5 million, a 22 percent increase over...

January 25, 2010



Thoratec Announces Acquisition of Innovative Catheter-Based Heart Pump Technology

COMPANY WILL INITIATE PRODUCT DEVELOPMENT EFFORT FOR PERCUTANEOUS, ACUTE CARDIAC SUPPORT OFFERINGPLEASANTON, Calif., Jan 25, 2010 /PRNewswire via COMTEX/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support (MCS) therapies to save, support and restore failing hearts, said today that it has acquired an innovative catheter pump technology that it plans to use in the development of a minimally invasive, acute cardiac axial flow pump that can be delivered percutaneously in the cardiac catheterization lab and operating room. Thoratec is paying a cash purchase price of $8.5 million to Getinge AB (Stockholm: GETIB) for the technology, which will be...

News from ITC

• July 15, 2009

  
  MAS to Integrate ITC’s AVOXimeter® 4000 and AVOXimeter 1000E to RALS®-Plus

  International Technidyne Corporation (ITC) and Medical Automation Systems, Inc. (MAS) announced that they have entered into an agreement to add the ITC® AVOXimeter 4000 CO-oximeter and the AVOXimeter 1000E oximeters to the RALS®-Plus point-of-care (POC) data management system developed and marketed by MAS.